“…45 According to other studies previously published by our research group, the level of adenosine in the serum of RA patients decreased. 47 Recently, a relationship between disease activity and serum E-ADA levels has been reported, which, in turn, may predict actual disease activity, as well as the response of treatment in RA. 33 It is important to note that adenosine, an ADA substrate, exhibits potent anti-inflammatory and immunosuppressive actions by inhibiting the proliferation of T cells, the secretion of cytokines and the migration of leukocytes across endothelial barriers.…”